Record Display for the EPA National Library Catalog

RECORD NUMBER: 178 OF 231

Main Title Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies
CORP Author European Commission. Scientific Committee on Emerging and Newly Identified Health Risks.
Publisher Scientific Committee on Emerging and Newly Identified Health Risks,
Year Published 2005
OCLC Number 62147467
Subjects Nanotechnology ; Risk assessment
Internet Access
Description Access URL
http://europa.eu.int/comm/health/ph_risk/committees/04_scenihr/docs/scenihr_o_003.pdf
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJBM  T174.7.E976 2005 Headquarters Library/Washington,DC 10/28/2005
Collation 78 p. ; 28 cm.
Notes
Adopted by the SCENIHR during the 7th plenary meeting of 28-29 September 2005. Includes bibliographical references (p. 62-77)
Contents Notes
Background -- Terms of Reference -- Scientific rational -- Introduction -- Definitions and scope -- Nanoscience and nanotechnology -- Examples of engineered nanostructures and materials and their applications -- Essentials of nanostructure generation: top-down vs. bottom-up chemical and physical self assembly -- Nanoscale materials properties -- Conclusions -- Nanoparticles: Physical and chemical particles -- Nanoparticle - nanoparticle interaction -- Sources of free nanoparticles -- Formation of nanoparticles in the liquid phase -- Formation of nanoparticles suspended in the gas phase -- Environmental sources of airborne nanoparticles -- Occupational sources of airborne nanoparticles -- Nanoparticles in and from consumer products -- Detection and measurement on nanoparticles -- In situ and on-line detection principles for nanoparticles in gas suspension -- In situ and on-line detection of particles in a liquid medium -- Potential for interactions between nanoparticles and living systems -- Nanoparticles in living systems - the surface effects -- Effects of size, shape, surface and bulk composition -- Solubility and persistence -- Toxicology of nanoparticles -- Mediators of the toxicity of particles -- Inhaled particles -- Particles for drug delivery -- Toxicological testing -- Exposure scenarios -- Sampling -- Exposure assessment methodologies -- General exposure considerations -- Hazard considerations -- Scope of nanoparticle risk assessment -- Exposure assessment methodology -- Hazard identification and hazard characterization methodology -- Risk characterization and integrated risk assessment -- Critical gaps in knowledge required for risk assessment purposes -- Regulatory and other aspects related to risk assessment -- Other needed developments -- Prioritisation of needs in knowledge -- Committee opinion -- Minority opinion.